Gross profit decreased 62.7%
Gross profit changed -62.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross profit changed -62.7% from the comparable as-filed period.
Revenue changed +7.9% from the comparable as-filed period.
Net income changed -624.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Stock-based compensation changed -23.6% from the comparable as-filed period.
SBC / revenue changed -31 basis points from the comparable as-filed period.
Research & development changed -8.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.